Hospital-Acquired Infection Control Market: Current Analysis and Forecast (2021-2027)

The global hospital-acquired infection control (HAIC) Market is anticipated to grow with an elevated CAGR of around 4% over the forecast period (2021-2027). Hospital-Acquired Infections are the infections that occur in hospitals due to contaminated equipment, furniture, washrooms, or others. Diseases like sepsis, tuberculosis, and influenza are commonly spread from hospitals.

With the rapid advancement in sterilization technology and rising awareness about personal and environmental hygiene, many industry players are focusing on expanding their portfolio by launching new services and products in the market. Thus, supporting the HAIC market growth during the forecast period. For example, in August 2021- STERIS announced the addition of Vesta-Syde SQ 64 st Ready-to-Use Disinfectant Wipes to its comprehensive disinfectant product line. Vesta-Syde SQ 64 st Ready-to-Use (RTU) Disinfectant Wipes use an innovative system that combines cleanroom quality wipes packaged with a separate internal pouch containing the quaternary ammonium active ingredient. The internal pouch allows for maximum chemical stability while offering a simple, convenient, and consistent method to saturate the wipes. Furthermore, the demand for HAIC is increasing on account of the growth in the aging population coupled with the rising prevalence of numerous chronic diseases across the globe.

STERIS plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, MATACHANA GROUP, MMM Group, Belimed AG, Reckitt Benckiser., are some of the prominent players operating in the Hospital- Acquired Infection Control (HAIC) market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of Hospital- Acquired Infection Control (HAIC) devices.

Insights Presented in the Report

"Amongst Product & Services, protective barriers segment holds the major share"

Based on products & services, the market is segmented into protective barriers, sterilization, disinfectants, disinfectors, endoscope reprocessing products, and others. The protective barriers segment accounted for a significant market share in 2020 and it is estimated that it will exhibit a higher CAGR during the forecast period. The growth of this segment is mainly due to the increasing number of HAIs globally. According to CDC, there is a significant increase in the HAI events such as central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), surgical site infections (SSIs), and methicillin-resistant Staphylococcus aureus (MRSA) bloodstream events between 2019 and 2020. VAEs increased by 35%, CLABSI increased by 24%, and MRSA increased by 15%. Furthermore, the lower product cost and easy availability significantly contribute to the market of HAIs during the forecast period.

"Amongst End-user, senior citizen segment holds the major share"

Based on end-user, the market is divided into hospitals & ICUs, ambulatory surgical & diagnostic centers, and others. The hospital segment grabbed a significant market share in 2020 and is anticipated to grow at a steady rate in the upcoming years owing to the rapidly increasing geriatric population and rising prevalence of various chronic diseases among them. For instance, as per the WHO, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. Also, 1 in 6 people in the world will be aged 60 years or over by 2030. Moreover, the increasing investments in better healthcare infrastructure and increasing government and WHO regulations for disease control are likely to positively influence the segment in the HAI control market during the forecast period.

"APAC represents one of the largest markets of Hospital- Acquired Infection Control (HAIC) market"

For a better understanding of the market dynamics of the Hospital- Acquired Infection Control (HAIC) market, a detailed analysis was conducted for different regions across the globe including North America (U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major share in the industry. The major factors such as favorable government initiatives, and increased investments in research and development to reduce risk from HAI coupled with the rapid increase in the geriatric population are propelling the growth of this market in the region. For instance, the number of Americans aged 60 and older increased by 34% from 55.7 million to 74.6 million between 2009 and 2019.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The global Hospital- Acquired Infection Control (HAIC) market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.